Liege, Belgium, 8 February 2023 – 17:45 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, took note of the statements made in the press release of its Estetrol manufacturer.
At this stage, Mithra does not comment on those statements.
The payments in question are formally disputed and part of a broader complex factual situation.
These amounts have been provisioned and Mithra takes appropriate measures to protect its interests and those of its stakeholders.
Mithra will inform the market in due time in compliance with its obligations as a listed company.